Professional
Added to YB: 2025-02-24
Pitch date: 2024-12-31
NTRA [bullish]
Natera, Inc.
+78.63%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
Market Cap
$40.0B
Pitch Price
$158.88
Price Target
N/A
Dividend
N/A
EV/EBITDA
-159.25
P/E
-170.83
EV/Sales
15.66
Sector
Biotechnology
Category
growth
Show full summary:
Alger Small Cap Focus Fund Portfolio Holding: Natera, Inc.
NTRA: Specialty lab for genetic testing in reproductive health, oncology & transplant. Q3 beat on Signatera growth & women's health market share gains. Gross margins expanding on pricing & cost control. Proprietary liquid biopsy platform for cell-free DNA detection. Productivity initiatives like cheaper sequencing to boost earnings.
Read full article (1 min)